Local generation of C-reactive protein in diseased coronary artery venous bypass grafts and normal vascular tissue

Circulation

Volumn 108, Issue 12, 2003, Pages 1428-1431

  Jabs, Wolfram J ^a   Theissing, Elisabeth ^a   Nitschke, Martin ^a   Bechtel, J F Matthias ^a   Duchrow, Michael ^a   Mohamed, Salah ^a   Jahrbeck, Bernhard ^a   Sievers, Hans Hinrich ^a   Steinhoff, Jürgen ^a   Bartels, Claus ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Atherosclerosis; Inflammation; Restenosis

Indexed keywords

ALPHA ACTIN; C REACTIVE PROTEIN; MESSENGER RNA; MONOCLONAL ANTIBODY;

ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; CORONARY ARTERY; DISEASE MARKER; HEART INFARCTION; HUMAN; HUMAN TISSUE; INTERNAL MAMMARY ARTERY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RADIAL ARTERY; SAPHENOUS VEIN; SMOOTH MUSCLE FIBER; VASCULAR TISSUE; VEIN BYPASS;

ARTERIOSCLEROSIS; C-REACTIVE PROTEIN; CORONARY ARTERY BYPASS; CORONARY RESTENOSIS; CORONARY VESSELS; GRAFT OCCLUSION, VASCULAR; HUMANS; IMMUNOHISTOCHEMISTRY; MAMMARY ARTERIES; MUSCLE, SMOOTH, VASCULAR; RADIAL ARTERY; RNA, MESSENGER; SAPHENOUS VEIN; VEINS;

EID: 0141727734     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000092184.43176.91     Document Type: Article

References (14)

1. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135-1143.
2. Ridker PM, Hennekens CH, Buring JE, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342:836-843.
3. Torzewski M, Rist C, Mortensen RF, et al. C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis. Arterioscler Thromb Vasc Biol. 2000;20: 2094-2099.
4. Zwaka TP, Hombach V, Torzewski J. C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation. 2001;103:1194-1197.
5. Pasceri V, Willerson JT, Yeh ETH. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation. 2000;102: 2165-2168.
6. Verma S, Wang CH, Li SH, et al. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation. 2002;106:913-919.
7. Torzewski J, Torzewski M, Bowyer DE, et al. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arterioscler Thromb Vasc Biol. 1998;18:1386-1392.
8. Zhang YX, Cliff WJ, Schoefl GI, et al. Coronary C-reactive protein distribution: its relation to development of atherosclerosis. Atherosclerosis. 1999;145:375-379.
9. Yasojima K, Schwab C, McGeer EG, et al. Generation of C-reactive protein and complement components in atherosclerotic plaques. Am J Pathol. 2001;158:1039-1051.
10. Jabs WJ, Lögering B, Gerke P, et al. The kidney as a second site of human C-reactive protein formation in vivo. Eur J Immunol. 2003;33:152-161.
11. Bartels C, Maass M, Bein G, et al. Association of serology with the endovascular presence of Chlamydia pneumoniae and cytomegalovirus in coronary artery and vein graft disease. Circulation. 2000;101:137-141.
12. Stary HC, Chandler AB, Dinsmore RE, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. Circulation. 1995;92:1355-1374.
13. Vainas T, Lubbers T, Stassen FRM, et al. Serum C-reactive protein level is associated with abdominal aortic aneurysm size and may be produced by aneurysmal tissue. Circulation. 2003;107:1103-1105.
14. Diehl EE, Haines III GK, Radosevich JA, et al. Immunohistochemical localization of modified C-reactive protein antigen in normal vascular tissue. Am J Med Sci. 2000;319:79-83.